Issues related to emerging biological threats and drug development
Source-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 21, 2026
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- THE VOGEL GROUP
- Client
- HDT BIO CORP
- Filing UUID
- 378ca162-a6c1-4556-b54f-6ab281fa8763
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to emerging biological threats and drug development
Issues related to emerging biological threats and drug development
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.